Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone and Sulbactam for Uncomplicated Urogenital Gonorrhea
NCT04202068Phase 4Completed
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- Jul 2015
- Primary completion
- May 2016
- Modality
- Reversible Covalent Inhibitors
01
Overview
A Phase 4 trial of ceftriaxone, sulbactam in gonorrhea, sponsored by Xiangbei Welman Pharmaceuticals. Started Jul 2015; status: completed.
02
Drugs
ceftriaxonesulbactam
03
Conditions
gonorrhea
Beyond the preview
Go deeper on NCT04202068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04202068.